From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare Population.

Thomas E DeleaQiufei MaGlenn S KroogWenzhen GeAaron MoynahanNatalia Sabater AnayaKaren Rodriguez LorencXue Song

Published in: Oncology and therapy (2024)

In this study across a spectrum of Medicare TCE patients, there was heterogeneity in treatment regimens, suggesting no standard of care. TTD and OS were short, and HRU and HCC were high. These results underscore the potential for new therapies in this population.

Keyphrases

end stage renal disease
newly diagnosed
palliative care
prognostic factors
single cell
risk assessment
climate change
combination therapy
human health
smoking cessation